Do Certain Biomarkers Predict Adverse Outcomes in Coronavirus Disease 2019?
Adverse outcomes
Biomarkers
COVID-19
Mortality
Novel corona virus pneumonia
SARS-CoV-2
Journal
Journal of clinical medicine research
ISSN: 1918-3003
Titre abrégé: J Clin Med Res
Pays: Canada
ID NLM: 101538301
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
05
06
2020
accepted:
22
08
2020
entrez:
19
5
2021
pubmed:
20
5
2021
medline:
20
5
2021
Statut:
ppublish
Résumé
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Given the rapid spread of the disease, the World Health Organization (WHO) declared the 2019 - 2020 coronavirus outbreak a Public Health Emergency of International Concern (PHEIC) on January 30, 2020, and a pandemic on March 11, 2020. There have been several reports of the limited resources including the lack of intensive care unit (ICU) beds and mechanical ventilators. Thus, biomarkers that predict ICU stay and mortality will be an important tool to appropriately allocate the limited resources. The aim of this review was to identify laboratory markers that can effectively predict the risk of severe infection and increased mortality in COVID-19 cases. We conducted a systematic review of existing literature in six databases to evaluate the predictive value of various biomarkers. We used the keywords "COVID-19", "SARS-CoV-2", "Novel corona virus pneumonia", "Biomarkers", "Adverse outcomes", "Mortality", etc. among many others to refine our search. Several biomarkers were identified to be associated with adverse outcomes in the above studies. These biomarkers can be used as a tool to identify patients at increased risk for adverse outcomes so that the need for aggressive critical care in such patients is met.
Identifiants
pubmed: 34007357
doi: 10.14740/jocmr4254
pmc: PMC8110220
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
195-203Informations de copyright
Copyright 2021, Narvel et al.
Déclaration de conflit d'intérêts
None to declare.
Références
Biochem Biophys Res Commun. 2020 May 21;526(1):165-169
pubmed: 32201080
Prog Cardiovasc Dis. 2020 May - Jun;63(3):390-391
pubmed: 32169400
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
J Med Virol. 2020 Oct;92(10):2152-2158
pubmed: 32406952
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
Platelets. 2020 May 18;31(4):490-496
pubmed: 32297540
Med Mal Infect. 2020 Jun;50(4):332-334
pubmed: 32243911
J Am Coll Cardiol. 2020 Sep 8;76(10):1244-1258
pubmed: 32652195
J Med Virol. 2020 Sep;92(9):1533-1541
pubmed: 32181903
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Jul 24;48(7):567-571
pubmed: 32141280
Blood Coagul Fibrinolysis. 2003 Dec;14(8):745-8
pubmed: 14614354
Intensive Care Med. 2020 May;46(5):837-840
pubmed: 32123994
Clin Chim Acta. 2020 Jul;506:145-148
pubmed: 32178975
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
JAMA Cardiol. 2020 Jul 1;5(7):811-818
pubmed: 32219356
N Engl J Med. 2020 May 21;382(21):2049-2055
pubmed: 32202722
Liver Int. 2020 Sep;40(9):2095-2103
pubmed: 32239796
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Crit Care Med. 2006 Jun;34(6):1725-30
pubmed: 16625114
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
J Med Virol. 2020 Jul;92(7):856-862
pubmed: 32281668
Kidney Int. 2020 May;97(5):829-838
pubmed: 32247631
Lancet Rheumatol. 2020 Aug;2(8):e474-e484
pubmed: 32835257
JAMA Cardiol. 2020 Jul 1;5(7):802-810
pubmed: 32211816
J Nephrol. 2020 Aug;33(4):737-745
pubmed: 32602006
BMJ. 2020 Mar 26;368:m1091
pubmed: 32217556
J Thromb Thrombolysis. 2021 May;51(4):1107-1110
pubmed: 32246317
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Card Fail Rev. 2020 May 25;6:e15
pubmed: 32537248
Clin Chim Acta. 2020 Jun;505:190-191
pubmed: 32145275
J Infect. 2020 Jun;80(6):639-645
pubmed: 32240670
Med Mal Infect. 2020 Jun;50(4):382-383
pubmed: 32259560
Am J Respir Cell Mol Biol. 2000 Apr;22(4):401-4
pubmed: 10745020
Cell Biosci. 2020 Mar 16;10:40
pubmed: 32190290
Rev Med Virol. 2020 Nov;30(6):1-9
pubmed: 32845568
Clin Chem Lab Med. 2020 Jun 25;58(7):1116-1120
pubmed: 32172226
J Intensive Care. 2020 May 24;8:36
pubmed: 32483488
J Card Fail. 2020 Jun;26(6):470-475
pubmed: 32315733
Nat Rev Cardiol. 2020 May;17(5):259-260
pubmed: 32139904
Hepatol Int. 2020 Sep;14(5):621-637
pubmed: 32710250
Aging (Albany NY). 2020 Jun 24;12(12):11245-11258
pubmed: 32633729